Moreover, this method should work for other cancer susceptibility genes for which the penetrance is high enough (e.g., TP53, PALB2) and/or there are rare cancers associated with pathogenic variants in the given gene that personal/family history is predictive of carrier status. This evidence concerns the gene TP53 and cancer.